Fractyl Health Receives FDA IDE Approval for the Revita®
Revita aims to be the first approved therapeutic option for durable weight maintenance after discontinuation of GLP-1 based drugs, as ...
Read moreRevita aims to be the first approved therapeutic option for durable weight maintenance after discontinuation of GLP-1 based drugs, as ...
Read moreA single Revita endoscopic procedure resulted in 3.4% mean total body weight loss by Week 4 in patients with advanced ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.